Capula Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,465
Closed -$131K 808
2026
Q1
$105K Buy
+1,465
New +$113K ﹤0.01% 894
2025
Q4
Sell
-12,436
Closed -$980K 847
2025
Q3
$938K Sell
12,436
-7,049
-36% -$483K ﹤0.01% 366
2025
Q2
$1.34M Buy
19,485
+17,911
+1,138% +$1.17M 0.01% 155
2025
Q1
$107K Buy
+1,574
New +$94.2K ﹤0.01% 615
2023
Q4
Sell
-38,596
Closed -$2.75M 358
2023
Q3
$2.69M Buy
+38,596
New +$2.73M 0.06% 130
2023
Q2
Sell
-236,816
Closed -$17.6M 505
2023
Q1
$17.6M Sell
236,816
-101,501
-30% -$8.51M 0.21% 98
2022
Q4
$31.5M Buy
338,317
+151,151
+81% +$14.6M 0.42% 59
2022
Q3
$17.9M Buy
187,166
+9,999
+6% +$990K 0.24% 116
2022
Q2
$16.4M Buy
177,167
+116,885
+194% +$11.4M 0.28% 95
2022
Q1
$6.1M Buy
60,282
+53,992
+858% +$5.67M 0.09% 174
2021
Q4
$649K Sell
6,290
-9,654
-61% -$892K 0.01% 162
2021
Q3
$1.34M Sell
15,944
-132,082
-89% -$11.1M 0.02% 473
2021
Q2
$12.3M Buy
148,026
+143,859
+3,452% +$11.8M 0.2% 100
2021
Q1
$313K Buy
+4,167
New +$304K 0.01% 422
2020
Q2
Sell
-43,858
Closed -$2.76M 334
2020
Q1
$2.6M Buy
+43,858
New +$2.93M 0.09% 232

Other funds holding CVS

Capula Management's CVS Position: Q2 2026 in Review

Capula Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 1,465 shares — an estimated $131K sold.

Capula Management first reported a position in CVS in Q1 2020 and held it in 15 quarters. The position peaked at $31.5M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Capula Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 1,465 CVS Health shares in Q2 2026, an estimated $131K.
  • Capula Management first reported a position in CVS Health in Q1 2020 and held it in 15 quarters.
  • Capula Management's CVS Health position peaked at $31.5M in Q4 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.